Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: review of current phase III immunotherapy clinical trials

The treatment of advanced stage, metastatic or recurrent endometrial cancer remains a clinically difficult scenario. Although combination carboplatin and paclitaxel is an effective standard-of-care regimen, alternate strategies have shown promise, particularly in biomarker select populations. In an...

Descripción completa

Detalles Bibliográficos
Autores principales: Eskander, Ramez N., Powell, Matthew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Immunotherapy in Gynecological Cancers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970168/
https://www.ncbi.nlm.nih.gov/pubmed/33796152
http://dx.doi.org/10.1177/17588359211001199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970168/
https://www.ncbi.nlm.nih.gov/pubmed/33796152
http://dx.doi.org/10.1177/17588359211001199

Ejemplares similares